Global, regional, and national burden of male breast cancer in 204 countries and territories: a systematic analysis from the global burden of disease study, 1990-2021

被引:0
|
作者
Li, Yunhai [1 ]
Huang, Ying [1 ]
Huang, Hongbo [1 ]
Wei, Tingting [1 ]
Zhang, Aijie [2 ]
Xing, Lei [1 ]
Yin, Xuedong [1 ]
Li, Hongyuan [1 ]
Ren, Guosheng [1 ,3 ]
Li, Fan [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Breast & Thyroid Surg, 1 Youyi Rd, Chongqing 400016, Peoples R China
[2] Chongqing Med Univ, Univ Town Hosp Affiliated, Hlth Management Ctr, Chongqing, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Mol Oncol & Epigenet, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
Male breast cancer; Global burden; Epidemiology; Lifetime risk; POPULATION; RISK; MORTALITY; TRENDS;
D O I
10.1016/j.eclinm.2024.103027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Male breast cancer (MBC) is a rare malignancy that has been under-investigated, with limited global epidemiological research dedicated to it. A comprehensive estimate of the global, regional, and national burden of MBC is valuable for policy planning. This study aims to evaluate the burden of MBC across 204 countries and territories. Methods MBC data were collected from the 2021 Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study estimates spanning from 1990 to 2021. The global incidence, prevalence, deaths, and disability-adjusted life-years (DALYs) attributed to MBC, as well as corresponding age-standardized rates, were calculated. Temporal trends, projections of incidence and mortality to 2050, lifetime risk, and risk factors of MBC were also estimated according to regions and countries. Findings In 2021, there were 38,827 (95% uncertainty interval [UI], 24,650-47,846) new cases, 320,459 (95% UI, 220,533-384,317) prevalent cases, 13,274 (95% UI, 9074-16,240) deaths, and 380,917 (95% UI, 252,922-476,417) DALYs attributed to MBC worldwide, with the highest disease burden observed in the Eastern Sub-Saharan Africa region. From 1990 to 2021, the age-standardized incidence and mortality rates of MBC significantly increased, but they are projected to decrease over the next 30 years. High-middle Socio-demographic Index (SDI) quintile had the highest lifetime risk of developing MBC, while the low SDI quintile had the highest lifetime risk of dying from MBC. Dietary risk and alcohol use were identified as important risk factors for MBC deaths and DALYs globally. Interpretation The global burden of MBC significantly increased from 1990 to 2021, with notable geographic disparities. Efforts aimed at MBC prevention and control strategies should take into account the inequities in its global distribution. Funding This study was supported by the National Natural Science Foundation of China (grant numbers 82372996 and 82202913) and the Chongqing Natural Science Foundation (grant number CSTB2023NSCQ-MSX0480). Copyright (c) 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The Global, Regional, and National Burden of Pancreatitis in 204 Countries and Territories, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021
    Liu, Baiqi
    Zhang, Xinge
    Li, Jiarong
    Sun, Zefang
    Lin, Chiayen
    Ning, Caihong
    Hong, Xiaoyue
    Zhu, Shuai
    Shen, Dingcheng
    Chen, Lu
    Huang, Gengwen
    DIGESTIVE DISEASES AND SCIENCES, 2025,
  • [2] The global, regional, and national burden of myocarditis in 204 countries and territories, 1990-2021: Results from the Global Burden of Disease Study 2021
    Li, Le
    Ding, Ligang
    Wu, Lingmin
    Hu, Zhicheng
    Liu, Limin
    Zhao, Minghao
    Zhang, Tao
    Zheng, Lihui
    Yao, Yan
    EUROPEAN JOURNAL OF HEART FAILURE, 2024,
  • [3] Global, Regional, and National Burden of Male Breast Cancer, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021
    Wang, Long
    Wen, Ping
    Shao, Qing
    Jiang, Dongping
    Zhao, Yulan
    Zeng, Xiaohua
    CANCER MEDICINE, 2025, 14 (03):
  • [4] Global, regional, and national burden of tuberculosis and attributable risk factors for 204 countries and territories, 1990-2021: a systematic analysis for the Global Burden of Diseases 2021 study
    Yang, Huafei
    Ruan, Xinyi
    Li, Wanyue
    Xiong, Jun
    Zheng, Yuxin
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [5] GLOBAL, REGIONAL AND NATIONAL STROKE BURDEN AND ITS RISK FACTORS IN 204 COUNTRIES, 1990-2021: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2021
    Feigin, V.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 52 - 52
  • [6] Global, regional and national burden of decubitus ulcers in 204 countries and territories from 1990 to 2021: a systematic analysis based on the global burden of disease study 2021
    Zhang, Shenyue
    Wei, Guoxing
    Han, Liu
    Zhong, Weibing
    Lu, Zhentan
    Niu, Zehao
    FRONTIERS IN PUBLIC HEALTH, 2025, 13
  • [7] The global, regional, and national burden of oral cancer, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
    Wu, Junmeng
    Chen, He
    Liu, Yingjun
    Yang, Ruotong
    An, Na
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (02)
  • [8] Global, regional and national burden of liver cancer 1990-2021: a systematic analysis of the global burden of disease study 2021
    Jiang, Zhichao
    Zeng, Guoqiang
    Dai, Huajia
    Bian, Yuhao
    Wang, Libin
    Cao, Wei
    Yang, Junfeng
    BMC PUBLIC HEALTH, 2025, 25 (01)
  • [9] Global, regional and national burden of osteoarthritis in 1990-2021: a systematic analysis of the global burden of disease study 2021
    Wang, Zihao
    Xiao, Zhikang
    Sun, Changhao
    Xu, Gaoxiang
    He, Jianfeng
    BMC MUSCULOSKELETAL DISORDERS, 2024, 25 (01)
  • [10] Global, regional, and national burden of thalassemia, 1990-2021: a systematic analysis for the global burden of disease study 2021
    Tuo, Yuanyuan
    Li, Yang
    Li, Yan
    Ma, Jianjuan
    Yang, Xiaoyan
    Wu, Shasha
    Jin, Jiao
    He, Zhixu
    ECLINICALMEDICINE, 2024, 72